Atlas Trials

Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies

Clinical trial NCT02706392 · TERMINATED

Trial details

NCT number
NCT02706392
Sponsor
Fred Hutchinson Cancer Center
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmMetastatic Lung Non-Small Cell CarcinomaMetastatic Triple-Negative Breast CarcinomaRecurrent Acute Lymphoblastic LeukemiaRecurrent Mantle Cell LymphomaRefractory Chronic Lymphocytic LeukemiaStage III Lung Non-Small Cell Cancer AJCC v7Stage IIIA Lung Non-Small Cell Cancer AJCC v7Stage IIIB Lung Non-Small Cell Cancer AJCC v7Stage IV Breast Cancer AJCC v6 and v7Stage IV Lung Non-Small Cell Cancer AJCC v7
Start date
2016-03-16
Primary completion
2021-05-17
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.